Currently, there are 997.71M common shares owned by the public and among those 996.63M shares have been available to trade.
The company’s stock has a 5-day price change of 4.79% and 13.06% over the past three months. BKR shares are trading 10.15% year to date (YTD), with the 12-month market performance up to 5.97% higher. It has a 12-month low price of $28.32 and touched a high of $37.58 over the same period. BKR has an average intraday trading volume of 5.96 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.55%, 12.24%, and 14.83% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Baker Hughes Co (NASDAQ: BKR) shares accounts for 92.51% of the company’s 997.71M shares outstanding.
It has a market capitalization of $37.57B and a beta (3y monthly) value of 1.39. The stock’s trailing 12-month PE ratio is 19.06, while the earnings-per-share (ttm) stands at $1.98. The company has a PEG of 0.58 and a Quick Ratio of 0.86 with the debt-to-equity ratio at 0.38. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.54% over the week and 2.32% over the month.
Earnings per share for the fiscal year are expected to increase by 33.69%, and 22.63% over the next financial year. EPS should shrink at an annualized rate of 32.60% over the next five years, compared to 33.59% over the past 5-year period.
TD Cowen coverage for the Baker Hughes Co (BKR) stock in a research note released on January 25, 2024 offered a Outperform rating with a price target of $49. BofA Securities was of a view on July 12, 2023 that the stock is Buy, while CapitalOne gave the stock Overweight rating on June 07, 2023, issuing a price target of $38. UBS on their part issued Neutral rating on April 19, 2023.
